Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Feline Leukemia Virus P27 antibody

The Cell culture Monoclonal anti-Feline Leukemia Virus P27 antibody is suitable to detect Feline Leukemia Virus P27 in samples from Feline Leukemia Virus (FeLV). It has been validated for WB, EIA and PrA.
Catalog No. ABIN7385538
$1,386.00
Plus shipping costs $50.00
0.5 mg
Shipping to: United States
Delivery in 3 to 5 Business Days

Quick Overview for Feline Leukemia Virus P27 antibody (ABIN7385538)

Target

Feline Leukemia Virus P27

Reactivity

Feline Leukemia Virus (FeLV)

Host

  • 9
  • 5
  • 1
Cell culture

Clonality

  • 9
  • 6
Monoclonal

Conjugate

  • 8
  • 3
  • 2
  • 1
  • 1
Un-conjugated

Application

  • 11
  • 8
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA), Protein Assay (PrA)
  • Specificity

    Feline Leukemia Virus (FeLV) p27

    Cross-Reactivity (Details)

    Recognizes the p27 protein of Feline Leukemia Virus.

    Characteristics

    MAB to FeLV p27,MAb to FeLV p27 Monoclonal Antibody to MAb to Feline Leukemia Virus (FeLV) p27

    Purification

    > 90% pure by SDS-PAGE. Protein A Chromatography

    Purity

    > 90 %

    Immunogen

    Proprietary Immunogen

    Isotype

    IgG2b kappa
  • Application Notes

    3.6 mg/mL (OD280nm, E0.1 % = 1.4)

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    3.6 mg/mL

    Buffer

    10 mM Phosphate Buffered Saline, pH 7.2, 0.1 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 2-8°C for up to 2 weeks. For long term storage, aliquot and store at -20oC to avoid freeze/thaw cycles.
  • Target

    Feline Leukemia Virus P27

    Alternative Name

    Feline Leukemia Virus (FeLV) p27

    Target Type

    Viral Protein
You are here:
Chat with us!